Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105284
Filing Date
2025-08-08
Accepted
2025-08-07 18:05:12
Documents
59
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q revb-20250630.htm   iXBRL 10-Q 1466997
2 EX-31.1 revb-ex31_1.htm EX-31.1 33830
3 EX-31.2 revb-ex31_2.htm EX-31.2 33889
4 EX-32.1 revb-ex32_1.htm EX-32.1 12475
5 EX-32.2 revb-ex32_2.htm EX-32.2 13181
  Complete submission text file 0000950170-25-105284.txt   7136663

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20250630.xsd EX-101.SCH 1394404
62 EXTRACTED XBRL INSTANCE DOCUMENT revb-20250630_htm.xml XML 1034546
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39603 | Film No.: 251195638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)